A290660 Stock Overview
Researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Neofect Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩857.00 |
| 52 Week High | ₩1,580.00 |
| 52 Week Low | ₩826.00 |
| Beta | 0.77 |
| 11 Month Change | -9.02% |
| 3 Month Change | -15.23% |
| 1 Year Change | -33.20% |
| 33 Year Change | -71.99% |
| 5 Year Change | -80.74% |
| Change since IPO | -88.87% |
Recent News & Updates
Shareholder Returns
| A290660 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -6.4% | 8.1% | 2.9% |
| 1Y | -33.2% | 11.5% | -2.8% |
Return vs Industry: A290660 underperformed the KR Medical Equipment industry which returned 11.5% over the past year.
Return vs Market: A290660 underperformed the KR Market which returned -2.8% over the past year.
Price Volatility
| A290660 volatility | |
|---|---|
| A290660 Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A290660 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A290660's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 49 | Ho-young Ban | www.neofect.com |
Neofect Co., Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high-tech medical device that develops users' shoulder and upper arm movements to promote improved functional reach and muscle control; Neofect Smart Balance to practice balance and posture during real-world training scenarios; and Neofect Smart Pegboard, a digital pegboard for functional and cognitive rehabilitation. It also provides Neofect Smart Table for dementia prevention and rehabilitation program; Neomano, a wearable robotic glove; Neofect Comcog, a cognitive rehabilitation program that helps patients with stroke, dementia, traumatic brain injury, brain tumor, and cerebral palsy; and Neofect TeleRehab, a teletherapy platform designed for remote rehabilitation, as well as a range of orthotic and assistive devices.
Neofect Co., Ltd. Fundamentals Summary
| A290660 fundamental statistics | |
|---|---|
| Market cap | ₩40.85b |
| Earnings (TTM) | -₩1.27b |
| Revenue (TTM) | ₩23.11b |
1.7x
P/S Ratio-30.9x
P/E RatioIs A290660 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A290660 income statement (TTM) | |
|---|---|
| Revenue | ₩23.11b |
| Cost of Revenue | ₩13.92b |
| Gross Profit | ₩9.19b |
| Other Expenses | ₩10.47b |
| Earnings | -₩1.27b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -27.69 |
| Gross Margin | 39.78% |
| Net Profit Margin | -5.51% |
| Debt/Equity Ratio | 57.5% |
How did A290660 perform over the long term?
See historical performance and comparison